| Melida Yudit Tellez, MD | |
|
16605 Southwest Fwy Ste 400, Sugar Land, TX 77479-3500 | |
| (281) 275-0800 | |
| Not Available |
| Full Name | Melida Yudit Tellez |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 16605 Southwest Fwy Ste 400, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528296084 | NPI | - | NPPES |
| 333099503 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | P1237 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Home Health Of Houston | Richmond, TX | Home health agency |
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Houston Methodist West Hospital | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
PRI's "The World" reports on malnutrition in India, where "eight million children ... suffer from severe acute malnutrition, according to the Indian government." However, the news service writes that "when it comes to treating those children, India lacks what many consider one of the best tools available: so-called ready-to-use therapeutic foods," such as "the most well-known therapeutic food, Plumpy'Nut, ... a patented concoction of peanut butter and micro-nutrients that allows severely malnourished children to be treated at home instead of at a hospital."
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this disease, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
A low hemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
Although super-resolution light microscopy has broken new ground in our understanding of subcellular structures and the movement of individual molecules within cells, its use to investigate virus particles is in its infancy...
› Verified 3 days ago
| Entity Name | Sugar Land Family Practice, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780636779 PECOS PAC ID: 2264443514 Enrollment ID: O20060526000041 |
News Archive
PRI's "The World" reports on malnutrition in India, where "eight million children ... suffer from severe acute malnutrition, according to the Indian government." However, the news service writes that "when it comes to treating those children, India lacks what many consider one of the best tools available: so-called ready-to-use therapeutic foods," such as "the most well-known therapeutic food, Plumpy'Nut, ... a patented concoction of peanut butter and micro-nutrients that allows severely malnourished children to be treated at home instead of at a hospital."
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this disease, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
A low hemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
Although super-resolution light microscopy has broken new ground in our understanding of subcellular structures and the movement of individual molecules within cells, its use to investigate virus particles is in its infancy...
› Verified 3 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
PRI's "The World" reports on malnutrition in India, where "eight million children ... suffer from severe acute malnutrition, according to the Indian government." However, the news service writes that "when it comes to treating those children, India lacks what many consider one of the best tools available: so-called ready-to-use therapeutic foods," such as "the most well-known therapeutic food, Plumpy'Nut, ... a patented concoction of peanut butter and micro-nutrients that allows severely malnourished children to be treated at home instead of at a hospital."
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this disease, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
A low hemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
Although super-resolution light microscopy has broken new ground in our understanding of subcellular structures and the movement of individual molecules within cells, its use to investigate virus particles is in its infancy...
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melida Yudit Tellez, MD 16605 Southwest Fwy Ste 400, Sugar Land, TX 77479-3500 Ph: (281) 275-0800 | Melida Yudit Tellez, MD 16605 Southwest Fwy Ste 400, Sugar Land, TX 77479-3500 Ph: (281) 275-0800 |
News Archive
PRI's "The World" reports on malnutrition in India, where "eight million children ... suffer from severe acute malnutrition, according to the Indian government." However, the news service writes that "when it comes to treating those children, India lacks what many consider one of the best tools available: so-called ready-to-use therapeutic foods," such as "the most well-known therapeutic food, Plumpy'Nut, ... a patented concoction of peanut butter and micro-nutrients that allows severely malnourished children to be treated at home instead of at a hospital."
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this disease, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
A low hemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
Although super-resolution light microscopy has broken new ground in our understanding of subcellular structures and the movement of individual molecules within cells, its use to investigate virus particles is in its infancy...
› Verified 3 days ago
Monica Kalra, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14023 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-325-4100 | |
Dr. Brent Devin Reed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15200 Southwest Fwy Ste 175, Sugar Land, TX 77478 Phone: 713-461-2915 Fax: 713-461-5307 | |
Robbyn Lucille Traylor, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2415 Town Center Dr, Ste 300, Sugar Land, TX 77478 Phone: 281-201-0657 | |
Dr. Cedela Abdulla, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3533 Town Center Blvd S, Ste. 200, Sugar Land, TX 77479 Phone: 713-772-0793 Fax: 281-781-2557 | |
Wyntria Lacabe-moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1403 Highway 6, Sugar Land, TX 77478 Phone: 832-260-0640 | |
Dr. Abraham K. Peringol, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14815 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-565-2140 Fax: 281-565-2174 | |
Owen Capocyan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4911 Sandhill Dr, Sugar Land, TX 77479 Phone: 816-334-9302 |